No Data
No Data
Better Cathie Wood Stock: Moderna Vs. Intellia
Update: Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals
(Updates with Regeneron's response in the third paragraph and the latest stock move of Intellia and Regeneron in the fifth paragraph.) Intellia Therapeutics (NTLA) said in a Friday filing that it has
Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals
Intellia Therapeutics (NTLA) said in a Friday filing that it has decided to end its 2020 agreement with Regeneron Pharmaceuticals (REGN) on developing gene editing products directed to factor IX, a bl
Intellia Opts Out of Hemophilia Pact With Regeneron
Express News | Intellia Therapeutics On March 19, Notified Regeneron Pharmaceuticals That Co Is Opting Out Of Its Factor IX Co-Development And Co-Funding Agreement
Intellia (NTLA) Begins Dosing in Phase III ATTR Amyloidosis Study
No Data